ESMO (European Society for Medical Oncology) shared a post on LinkedIn:
“Dr. Pawel Sobczuk and Dr. Christopher Oing highlight the value of the ESMO Sarcoma and Rare Cancers Congress 2025 (20–22 March, Lugano, Switzerland) for advancing oncology research and career development.
Late registration available until 19 February – secure your place today!”
More posts featuring ESMO.